Related Experiment Videos
Commentary: Quantifying the Human Mortality Costs of Patent-Based Intellectual Property: How Many Premature Deaths
Kristina M L Acri Née Lybecker1
1Gerald L. Schlessman Professor of Economics, Colorado College, Colorado Springs, CO, USA. kacri@coloradocollege.edu.
Abstract:
This comment reviews he article, "Quantifying the HumanMortality Costs of Patent-based Intellectual Property: How Many PrematureDeaths are due to Patents?", by Joshua M. Pearce and argues that the analysisis overly simplistic.While theaffordability of medicine is a troubling challenge, one must examine thebenefits of intellectual property protection as well as the costs in order toprovide meaningful analysis.By failingto do so the author does us all a disservice by blaming the IP system, anobvious target.The truth is far morenuanced and serious readers deserve an analysis that reflects this and shedslight on the subtleties of the problem rather than turning to an easyscapegoat.Keywords: intellectual property, patents, insulin.
Related Concept Videos
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Kaplan-Meier Approach
Animal Mitochondrial Genetics
Genomic Imprinting and Inheritance
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Population Growth
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...